Arvinas reported early-stage data for its PROTAC program in healthy volunteers, hoping the results will eventually translate to patients with Parkinson’s disease. The data, which were shared ...

AnaptysBio trumpeted a Phase 2b success in rheumatoid arthritis Wednesday morning after a similar program from Eli Lilly was discontinued late last year.

Relmada Therapeutics said Wednesday morning that a Phase 3 study testing its major depression drug, REL-1017, is likely to fail, cratering its stock price.

End­points 11 win­ner As­cid­i­an Ther­a­peu­tics: A search-and-re­place tech­nol­o­gy comes to RNA ...

Septerna is joining biotech's IPO on-deck circle, preparing for a public offering with two other startups that have similar ambitions. It announced its plans in a securities filing Wednesday ...

The federal government renewed its threats to Johnson & Johnson on Friday over the company’s proposal to change how some hospitals receive drug price discounts under the 340B program. ...

Gilead announced that its twice-a-year HIV injection prevented all but two cases of HIV among 2,180 participants in a Phase 3 study as it prepares to launch the drug, called ...

The FDA has approved Johnson & Johnson’s IL-23 blocker Tremfya to treat ulcerative colitis, a boost to the pharma’s hopes that the drug will serve as a worthy follow-up to ...

The FDA has authorized emergency use of Novavax’s updated Covid booster, just over a week after clearing updated versions of mRNA boosters from Pfizer and Moderna. ...

BioMarin is bringing prominent dealmaker James Sabry onto its executive team, along with Amgen rare disease veteran Greg Friberg. Sabry will start on Oct. 7 as chief business officer, following ...

San Francisco-based investment firm venBio plans to back about a dozen new biotech startups over the coming three years with its latest fund, disclosed Thursday morning. The firm attracted ...

A federal appeals court has unanimously rejected an attempt by a group of Republican states to intervene in a lawsuit seeking fewer restrictions for the abortion pill mifepristone. Mifepristone is ...